טוען...
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
It is thought that KRAS oncoproteins are constitutively active because their guanosine triphosphatase (GTPase) activity is disabled. Consequently, drugs targeting the inactive or guanosine 5′-diphosphate–bound conformation are not expected to be effective. We describe a mechanism that enables such d...
שמור ב:
| הוצא לאור ב: | Science |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955282/ https://ncbi.nlm.nih.gov/pubmed/26841430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aad6204 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|